You are viewing the "Gilead" Archives
Gilead Lobbying Rose As Interest In COVID-19 Treatment Climbed
By: Sydney Lupkin | NPR
Posted on:
On Friday, the Food and Drug Administration authorized emergency use of remdesivir for patients with severe cases of COVID-19. Drugmaker Gilead Sciences’ lobbying hit a new high in the first quarter.